PATENT CLAIM ANALYSIS

Application Number: 16130817
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["540", "521000"]

Abstract:
The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.

Claim (Index 30):
The compound of  claim 1 , wherein L is \u2014C(R g ) 2 \u2014 and two R 8  together with the carbon atom to which they are attached form a cycloalkyl ring.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.0625
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15424216', '15721470', '15721419', '15459141', '11925151']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6993284768351159
- 35 USC 102 Novelty (BERT): 0.5867042859861524
- Combined Prediction Score: 0.6880660577502196
- Mean Citation Score: 361.03180000000015
- Max Citation Score: 460.94983
- Similarity Product: 440.8346856913399

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test